Cite
HARVARD Citation
Fisher, A. et al. (2020). Rapid monitoring of health services utilization following a shift in coverage from brand name to biosimilar drugs in British Columbia—An interim report. Pharmacoepidemiology and drug safety. 29 (7), pp. 803-810. [Online].